Cyclacel Pharma (NASDAQ: CYCC) reported Q4 EPS of ($0.10), versus ($0.21) reported last year. Revenue for the quarter came in at $424 thousand, versus $247 thousand reported last year.

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.